The Valley Desk

NCT03601897 · Interventional trial

A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Locally Advanced or Metastatic Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov